• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802220
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/29/2018
Event Type  malfunction  
Manufacturer Narrative
The investigation has determined that a higher than expected vitros bhcg result was obtained when processing a patient sample on a vitros 5600 integrated system.The investigation was unable to determine the assignable cause for this event.There is no evidence to suggest a vitros 5600 system issue or a vitros bhcg ii reagent issue contributed to the event.Pre-analytical sample processing could not be ruled out as a contributing factor, as the customer is not adhering to the sample collection device manufacturer¿s recommendations for sample centrifugation.It is likely that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.
 
Event Description
A customer obtained a higher than expected vitros total bhcg (bhcg) result from a patient sample on a vitros 5600 integrated system.Patient sample, vitros bhcg result 13.34 miu/ml versus expected vitros bhcg result <2.39 miu/ml biased results of the direction and magnitude observed may lead to inappropriate medical action if not detected.The initial total bhcg ii result was reported to physicians, however, corrected reports were generated and there was no allegation of patient harm being made as a result of the event.This report corresponds to ortho clinical diagnostics inc.Complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK
Type of Device
IN VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key7637430
MDR Text Key112862341
Report Number3007111389-2018-00092
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Medical Technologist
Type of Report Initial
Report Date 06/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/26/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/02/2019
Device Catalogue Number6802220
Device Lot Number2080
Other Device ID Number10758750002320
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/30/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/13/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-